Zdrowie i gospodarka · 09/05/2025

FDA Classifies Microbial Nucleic Acid Storage and Stabilization Device into Class II with Special Controls

The US Food and Drug Administration (FDA) is classifying the microbial nucleic acid storage and stabilization device into Class II, requiring special controls, to ensure safety and effectiveness. This move aims to reduce regulatory burdens and increase access to innovative devices for patients.